Gan et al. demonstrated that treatment with an antioxidant compound (probucol) significantly increased Mfn2 and decreased Drp1 expression in cybrid cells obtained from neurons containing mitochondria from human AD or MCI patients. This evidence concerns the gene MFN2 and Alzheimer disease.